Chronic Eyelid Rash Management

Diagnostic Approach

The British Journal of Dermatology suggests that atopic dermatitis is a common inflammatory condition affecting the eyelids, particularly relevant in patients on dupilumab therapy who may develop dupilumab-related ocular surface disorders (DROSD) 1
The distribution pattern of unilateral vs bilateral involvement helps narrow the differential, with unilateral suggesting contact allergen exposure or sebaceous carcinoma, as noted by the Praxis Medical Insights 3
Associated symptoms such as crusting, scaling, discharge characteristics, and presence of follicular or papillary conjunctival reaction should be assessed, according to the Praxis Medical Insights 4

The Ophthalmology society recommends beginning with eyelid hygiene and warm compresses as the foundation of treatment, which must be continued long-term as symptoms recur when discontinued 2
Warm compresses should be applied to eyelids for 5-10 minutes, 3-4 times daily, and eyelid cleansing should be performed once or twice daily, as suggested by the Ophthalmology society 2
For atopic dermatitis/DROSD, the British Journal of Dermatology recommends mild disease treatment with preservative-free ocular lubricants, lid hygiene, and antihistamine drops, with warm compresses beneficial for meibomian gland dysfunction 1
The Ophthalmology society suggests that topical antibiotics such as bacitracin or erythromycin ointment may be used for blepharitis not responding to hygiene alone, with intermittent use of different antibiotics to prevent resistance 2

Failing to recognize concurrent conditions such as eyelid eczema with medial canthal discharge, which often represents two separate conditions requiring treatment of both, as noted by the Praxis Medical Insights 4
The Ophthalmology society warns against inadequate patient counseling, as patients must understand that eyelid hygiene requires long-term commitment as symptoms recur with discontinuation 2
The Praxis Medical Insights suggests that chronic unilateral blepharoconjunctivitis resistant to therapy warrants biopsy for sebaceous carcinoma 3
The British Journal of Dermatology recommends careful monitoring of prolonged topical corticosteroid use, with a maximum of 8 weeks for ocular corticosteroids without careful risk-benefit consideration and joint discussion with specialists 1